Literature DB >> 11058415

A viral etiology for Ewing's sarcoma.

J U Cope1.   

Abstract

Despite the finding of characteristic somatic mutations in the tumor tissue and efforts to identify risk factors, the etiology of Ewing's sarcoma (ES) is still unknown. ES is very different from other childhood bone cancers. It rarely occurs in the black population and has no animal model. Recently studies indicate that ES may have a neural, not mesenchymal, origin. It has a distinctive unimodal age-incidence peak at adolescence. Because its incidence curve pattern has a striking resemblance to that of DES-related clear cell adenocarcinoma of the vagina, an in utero exposure might be considered. Although in utero chemical and hormonal exposures have not been found to be associated with ES in epidemiologic studies, we suggest that its etiology could be an in utero viral infection. We hypothesize that the epidemiological characteristics of ES suggest an association with cytomegalovirus (CMV).

Entities:  

Mesh:

Year:  2000        PMID: 11058415     DOI: 10.1054/mehy.2000.1069

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Biomarkers for Bone Tumors: Discovery from Genomics and Proteomics Studies and Their Challenges.

Authors:  Wan I Wan-Ibrahim; Vivek A Singh; Onn H Hashim; Puteri S Abdul-Rahman
Journal:  Mol Med       Date:  2015-11-13       Impact factor: 6.354

2.  Primary paraesophageal Ewing's sarcoma: an uncommon case report and literature review.

Authors:  Noelia Tarazona; Lara Navarro; Juan Miguel Cejalvo; Valentina Gambardella; J Alejandro Pérez-Fidalgo; Alejo Sempere; Samuel Navarro; Andrés Cervantes
Journal:  Onco Targets Ther       Date:  2015-05-14       Impact factor: 4.147

3.  Frailty modeling of bimodal age-incidence curves of nasopharyngeal carcinoma in low-risk populations.

Authors:  Marion Haugen; Freddie Bray; Tom Grotmol; Steinar Tretli; Odd O Aalen; Tron A Moger
Journal:  Biostatistics       Date:  2009-03-29       Impact factor: 5.899

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.